Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Base Sequence × 1 year × Clear all

Phase

Status

Recruiting 4 Completed 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

pembrolizumab 320 Nivolumab 231 Carboplatin 229 Cyclophosphamide 220 Specimen Handling 218 Magnetic Resonance Spectroscopy 212 Cisplatin 180 Paclitaxel 177 Radiotherapy 164 Biopsy 144 Gemcitabine 138 Dexamethasone 132 durvalumab 128 atezolizumab 114 Rituximab 111 Lenalidomide 107 Doxorubicin 103 Bevacizumab 103 Ipilimumab 101 Radiation 94 Docetaxel 90 Pemetrexed 87 Etoposide 87 Capecitabine 87 fludarabine 86 Prednisone 86 venetoclax 84 Radiosurgery 82 Oxaliplatin 80 Fluorouracil 80

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03784014 2025-12-11

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Active not recruiting

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡